Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Stenting Strategies in Left Main Bifurcation
Author(s): Suryono Suryono , Muhammad Farhan Hibatulloh , Alfiyah Ramadhani , et al Added: 4 weeks ago

Intervention

Vascular Disease and Surgery
Non-cardiac Surgery Interventions on Patients Receiving Impella Support
Author(s): Mark Anderson , Nicolas Brozzi , Raul Rosenthal , et al Added: 2 years ago

Intervention
Cardiac State Optimisation to Promote Recovery During Extracorporeal Circulatory Support
Author(s): Steven Keller Added: 2 years ago

Intervention
Cardiac Denervation as a Treatment for Refractory Ventricular Arrhythmias
Author(s): Carolina Álvarez-Ortega , Josué Daniel Gómez-Martínez , María Alejandra Cardona-Gallardo , et al Added: 1 year ago

Electrophysiology & Arrhythmia

Intervention
TIMELY’s AI Revolution: Integrating AI in Cardiac Care
Author(s): Added: 12 months ago
TIMELY is an integrated AI-based healthcare solution consisting of a certified physician platform and a patient app. It has been developed within an EU-funded project running from 2021 to 2025. TIMELY aims to assist both cardiac patients and their clinicians in personalising healthcare by evaluating risks and offering individualised exercise recommendations. The solution has been evaluated within… View more

Intervention
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 11 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
Cardiac Energetics and Systemic Perfusion with VA-ECMO vs ECMELLA
Author(s): Peter Frederiksen , Ann Banke Added: 2 years ago

Intervention
NEO-MINDSET: Aspirin Withdrawal Post-PCI Fails to Show Noninferiority for Ischaemic Events
Added: 6 months ago Source:  Radcliffe Cardiology
Early withdrawal of aspirin in favour of potent P2Y12 inhibitor monotherapy following percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) did not meet the criteria for noninferiority regarding ischaemic events compared to standard dual antiplatelet therapy (DAPT), according to the results of the NEO-MINDSET trial.¹ The strategy did, however, demonstrate superiority in… View more

Anticoagulation

Guidelines & Statements
Supportive Care in Pulmonary Embolism
Author(s): Sylwia Sławek-Szmyt , Aleksander Araszkiewicz Added: 1 month ago

CV Disease in Special Populations

Heart Failure
FFR-Guided PCI Lowers MACE vs Angiography
Added: 4 months ago Source:  Transcatheter Academy
An individual patient data (IPD) meta-analysis has found that using fractional flow reserve (FFR) to guide percutaneous coronary intervention (PCI) is associated with a significant reduction in major adverse events compared to a standard angiography-guided strategy. The benefit appears to be driven primarily by a reduction in peri-procedural myocardial infarction (MI).¹The PRIME Collaboration… View more

Guidelines & Statements

Intervention